SI-BONE Inc (SIBN)
14.92
-0.21
(-1.39%)
USD |
NASDAQ |
May 17, 16:00
14.92
0.00 (0.00%)
After-Hours: 20:00
SI-BONE Research and Development Expense (Quarterly): 4.345M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.345M |
December 31, 2023 | 4.162M |
September 30, 2023 | 3.919M |
June 30, 2023 | 3.656M |
March 31, 2023 | 3.291M |
December 31, 2022 | 3.48M |
September 30, 2022 | 3.089M |
June 30, 2022 | 3.478M |
March 31, 2022 | 3.58M |
December 31, 2021 | 3.049M |
September 30, 2021 | 3.288M |
June 30, 2021 | 3.149M |
March 31, 2021 | 2.955M |
December 31, 2020 | 2.426M |
Date | Value |
---|---|
September 30, 2020 | 2.778M |
June 30, 2020 | 2.165M |
March 31, 2020 | 2.09M |
December 31, 2019 | 1.776M |
September 30, 2019 | 1.874M |
June 30, 2019 | 1.946M |
March 31, 2019 | 1.683M |
December 31, 2018 | 1.501M |
September 30, 2018 | 1.373M |
June 30, 2018 | 1.296M |
March 31, 2018 | 1.206M |
December 31, 2017 | 1.279M |
September 30, 2017 | 1.466M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.776M
Minimum
Dec 2019
4.345M
Maximum
Mar 2024
3.025M
Average
3.119M
Median
Research and Development Expense (Quarterly) Benchmarks
Conmed Corp | 13.59M |
TransMedics Group Inc | 11.38M |
Inari Medical Inc | 26.88M |
Electromed Inc | 0.167M |
Myomo Inc | 0.9562M |